SCHEMBL3221376

SCHEMBL3221376

CC(C)N(C)S(=O)(=O)c1ccccc1-c1ccc(C=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.54
OPRK1 P41145 4/20 0.54
ALOX5AP P20292 5/20 0.45
FEN1 P39748 5/20 0.45
DRD1 P21728 3/20 0.44
NAT1 P18440 1/20 0.43
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD5 P21918 1/20 0.40
DRD3 P35462 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDPK1 O15530 1/20 0.39
ROCK2 O75116 1/20 0.39
FES P07332 1/20 0.39
FER P16591 1/20 0.39
MARK3 P27448 1/20 0.39
FLT3 P36888 1/20 0.39
MAP4K2 Q12851 1/20 0.39
PKN2 Q16513 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904423 0.84 OPRM1 (0.58) OPRM1OPRK1ALOX5APFEN1ALDH1A1
SCHEMBL7803455 0.76 DRD1 (0.46) ALOX5APFEN1DRD1NAT1DRD2
SCHEMBL839417 0.76 DRD1 (0.46) DRD1NAT1DRD2DRD4DRD5
SCHEMBL6066480 0.75 LMNA (0.41) OPRM1OPRK1ALOX5APFEN1DRD1
SCHEMBL8511462 0.75 LMNA (0.41) OPRM1OPRK1ALOX5APFEN1DRD1
SCHEMBL6066470 0.75 LMNA (0.41) OPRM1OPRK1ALOX5APFEN1DRD1
SCHEMBL3204514 0.75 OPRK1 (0.70) OPRM1OPRK1ALDH1A1
SCHEMBL6066477 0.74 NAT1 (0.42) OPRM1OPRK1ALOX5APFEN1DRD1
SCHEMBL489577 0.73 ALOX5AP (0.55) ALOX5APFEN1NAT1
SCHEMBL1666926 0.72 DRD1 (0.60) DRD1NAT1DRD2DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035873-A1 Diaryl Compounds and Uses Thereof PFIZER INC 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035873-A1 Diaryl Compounds and Uses Thereof OPRK1, OPRD1, OPRL1 OPRM1 4/4885OPRK1 1/4885ALOX5AP 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.